Skip to content
Startups

Hemp-based skincare startup Hey Bud secures huge deal to supply 400 Priceline stores

By Wei Zhang
2 min read
Hemp-based skincare startup Hey Bud secures huge deal to supply 400 Priceline stores
In this article (5)

Hemp-powered skincare brand Hey Bud has rolled into more than 400 Priceline stores nationwide, as the startup readies for Australian authorities to embrace a greater variety of cannabis and CBD-infused products.

Hey Bud offers a range of serums, cleansers, and clay masks infused with hempseed oil, a natural product touted for its anti-inflammatory properties.

While hemp is derived from the cannabis plant family, hempseed oil contains no psychoactive ingredients — even if the Hey Bud name does cheekily allude to the plant’s more well-known cousin.

Officially launched in 2020 by Melbourne co-founders Alex Roslaniec, Ollie Watts, and Fedele D’Amico, Hey Bud commands its own webstore and an engaged, youthful fanbase with more than 210,000 Instagram followers.

The company claims to have made $10 million in sales in its brief history.

Partnering with Priceline will help the brand reach even more young customers, Roslaniec says, given the overlap between Hey Bud’s existing users and the pharmacy chain’s core customer base.

“What we found from speaking to a few different retailers was that Priceline’s customer demographic really made a lot of sense for us,” Roslaniec said

“So a lot of our customers do shop in the likes of Priceline, and they also have a very similar age demographic as well.”

“We know customers have been wanting to see our products on store shelves for a while now, and we are so excited to finally make that happen,” co-founder Ollie Watts said in a statement.

What we found from speaking to a few different retailers was that Priceline’s customer demographic really made a lot of sense for us,

The company is also exploring international distribution opportunities, Fedele added.

More broadly, the Priceline expansion will help Hey Bud on its mission of “actually educating our customers, and making sure that we are breaking down the stigma of cannabis because it doesn’t have this psychoactive component to it”.

At the same time, Hey Bud is keeping a keen eye on the CBD product market.

While doctors are free to prescribe pharmaceutical cannabis in certain circumstances, access to cannabis-based products like CBD oil is strictly regulated in Australia.

Given the prevalence of legalised CBD-infused consumer products in the US, Canada, and the UK, Roslaniec says customers are eager to hear about legislative developments at home.

“What we’re finding from a lot of our customers is they’re actually asking us, they’re looking to us for answers when CBD will become legal within Australia,” he said.

“I believe that it’s only a matter of time before CBD and cannabis become more recreationally legalised here in Australia which we are keeping a very close eye on,” he added.

The company is “talking to formulators overseas to understand what the process looks like as well so that we are ready to pivot into that space.”

Questions & Answers

Q.

What kind of products does Hey Bud offer to Priceline customers?

A.

Hey Bud sells a variety of skincare products, including serums, cleansers, and clay masks. These items are all infused with hempseed oil, which is known for its anti-inflammatory properties.

Q.

Why did Hey Bud choose to partner with Priceline for its expansion?

A.

The co-founders found a strong overlap between their existing customer base and Priceline's core demographic. Many Hey Bud customers already shop at Priceline, and the age groups are very similar.

Q.

How successful has Hey Bud been in terms of sales since its launch?

A.

Since launching in 2020, Hey Bud claims to have generated $10 million in sales. The brand also has a significant online presence, with over 210,000 Instagram followers.

Q.

What are Hey Bud's long-term goals regarding cannabis products in Australia?

A.

Hey Bud aims to educate customers and break down stigma surrounding cannabis without psychoactive components. They are also preparing for potential legislative changes that would allow more CBD and cannabis products in Australia.

Weekly Briefing

Asia's retail intelligence, in your inbox

Tuesday, Thursday and a Saturday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.

  • Top industry moves and market shifts
  • Weekly data-driven analysis from across Asia
  • Tuesday, Thursday and the Saturday Weekly Wrap

Read by retail operators, investors and brand teams across Asia.

Protected by a quick human check. No spam, ever. Unsubscribe in one click.

SecureGDPR ready